Related Experiment Video
Updated: Jun 5, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
The current status of stenting pathobiology
1Department of Medicine, University of Montreal, Montreal,Quebec,Canada H2L-4M1.
Trends in Cardiovascular Medicine
|January 18, 2011
Summary
Coronary stents improve arterial lumen after angioplasty but can cause vascular injury. This review examines arterial pathobiology linked to permanent and temporary stent use, despite reduced restenosis and thrombosis rates.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Pathobiology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) utilizes stents to maintain arterial lumen size.
- Stent deployment inherently causes vascular injury, posing risks like restenosis and thrombosis.
- Despite clinical advancements, restenosis and thrombosis remain limitations in coronary stent use.
Purpose of the Study:
- To review the arterial pathobiology associated with permanent and temporary coronary stents.
- To discuss the implications of vascular injury from stent deployment.
- To highlight ongoing challenges in stent-related complications.
Main Methods:
- Literature review of studies on coronary stent implantation.
- Analysis of pathobiological responses to vascular injury caused by stents.
- Examination of clinical trial data on restenosis and thrombosis rates.
Main Results:
- Stent deployment is a necessary but injurious component of PTCA.
- While rates of restenosis and thrombosis have decreased, they persist as clinical concerns.
- Understanding arterial pathobiology is crucial for mitigating stent-related complications.
Conclusions:
- Coronary stents are effective in maximizing arterial lumen post-PTCA.
- Vascular injury and subsequent pathobiological responses remain key areas of concern.
- Further research into stent pathobiology may lead to improved clinical outcomes.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...